Venus Medtech (Hangzhou) Inc Sustainability Reports
The company researches, develops, manufactures, and commercializes transcatheter heart valve medical devices. Its core product portfolio features minimally invasive treatment solutions for structural heart diseases, including transcatheter aortic heart valve replacements.
Sector: Manufacturing
Country: China
Exchange: Hong Kong Stock Exchange
FIGI: BBG00QTMSFX2
10 reports from 2019 to 2025